These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39431622)
21. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691 [TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1. Li M; Zhou J; Zhang Z; Li J; Wang F; Ma L; Tian X; Mao Z; Yang Y Chin Med J (Engl); 2022 Oct; 135(19):2326-2337. PubMed ID: 36535010 [TBL] [Abstract][Full Text] [Related]
23. Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Ma G; Li G; Fan W; Xu Y; Song S; Guo K; Liu Z Cell Death Dis; 2021 Jun; 12(7):656. PubMed ID: 34183642 [TBL] [Abstract][Full Text] [Related]
24. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer. Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741 [TBL] [Abstract][Full Text] [Related]
25. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b. Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592 [TBL] [Abstract][Full Text] [Related]
26. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression. Chen K; Wang Q; Liu X; Wang F; Yang Y; Tian X Int J Biol Sci; 2022; 18(3):1220-1237. PubMed ID: 35173549 [No Abstract] [Full Text] [Related]
27. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910 [TBL] [Abstract][Full Text] [Related]
28. LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. Lu Y; Ying D; Tian Y; Ruan Y; Cheng G; Lv K; Zhou X; Han S Clinics (Sao Paulo); 2022; 77():100047. PubMed ID: 35662010 [TBL] [Abstract][Full Text] [Related]
29. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Xie F; Li C; Zhang X; Peng W; Wen T Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891 [TBL] [Abstract][Full Text] [Related]
30. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p. Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551 [TBL] [Abstract][Full Text] [Related]
31. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p. Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026 [TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624 [TBL] [Abstract][Full Text] [Related]
33. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539. Nai Y; Pan C; Hu X; Ma Y Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465 [TBL] [Abstract][Full Text] [Related]
34. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway. Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507 [TBL] [Abstract][Full Text] [Related]
35. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
36. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development. Ma D; Wu J; Chen C; Niu Y; Ji K; Xiao Y; Guan Q Biochem Genet; 2024 Jun; 62(3):2082-2099. PubMed ID: 37851210 [TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation. Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression Wang HQ; Qian CH; Guo ZY; Li PM; Qiu ZJ World J Gastroenterol; 2022 Sep; 28(35):5141-5153. PubMed ID: 36188725 [TBL] [Abstract][Full Text] [Related]
39. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma. Yonemori K; Seki N; Kurahara H; Osako Y; Idichi T; Arai T; Koshizuka K; Kita Y; Maemura K; Natsugoe S Cancer Sci; 2017 Jan; 108(1):124-135. PubMed ID: 27862697 [TBL] [Abstract][Full Text] [Related]
40. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression. Takehara M; Sato Y; Kimura T; Noda K; Miyamoto H; Fujino Y; Miyoshi J; Nakamura F; Wada H; Bando Y; Ikemoto T; Shimada M; Muguruma N; Takayama T Cancer Sci; 2020 Aug; 111(8):2883-2894. PubMed ID: 32535957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]